OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Decreases in State and Trait Anxiety Post-psilocybin: A Naturalistic, Observational Study Among Retreat Attendees
Maggie Kiraga, Kim P. C. Kuypers, Malin V. Uthaug, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 15

Showing 15 citing articles:

Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis
Yuan Yao, Dan Guo, Tangsheng Lu, et al.
Psychiatry Research (2024) Vol. 335, pp. 115886-115886
Closed Access | Times Cited: 23

How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 29

Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14

Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey
Nicolas G. Glynos, Jacob S. Aday, Daniel J. Kruger, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 3

Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response
Abigail E. Calder, Benjamin Rausch, Matthias E. Liechti, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 873-886
Closed Access | Times Cited: 2

Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.
Miguel Farinha‐Ferreira, Catarina Miranda‐Lourenço, Chloé Galipeau, et al.
Neuropharmacology (2024) Vol. 266, pp. 110280-110280
Closed Access | Times Cited: 2

Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders
Stanley Wong, An Yi Yu, Nicholas Fabiano, et al.
Journal of Psychoactive Drugs (2023), pp. 1-17
Closed Access | Times Cited: 6

Associations between the use of psychedelics and other recreational drugs with mental health and resilience during the COVID-19 pandemic
Maria Bălăeţ, William Trender, Peter J. Hellyer, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 5

Neuroprotective effects of psilocybin in a rat model of stroke
Seong-Jin Yu, Kuo-Jen Wu, Yu-Syuan Wang, et al.
BMC Neuroscience (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history
Eric N. Kramer, Kalyn Reddy, Bryan B. Shapiro
Psychiatry Research Case Reports (2023) Vol. 2, Iss. 1, pp. 100118-100118
Open Access | Times Cited: 4

Page 1

Scroll to top